Skip to search formSkip to main contentSkip to account menu

diperoxovanadate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
To simulate the types of coordination and solution structures of the active site of haloperoxidases, the interaction systems… 
Highly Cited
2004
Highly Cited
2004
In vivo and in vitro studies indicate that 4-hydroxy-2-nonenal (4-HNE), generated by cellular lipid peroxidation or after… 
2003
2003
Diperoxovanadate (DPV), a potent inhibitor of protein tyrosine phosphatases and activator of tyrosine kinases, alters endothelial… 
2001
2001
We have shown earlier that oxidant-induced activation of phospholipase D (PLD) in vascular endothelial cells (ECs) is regulated… 
Highly Cited
2000
Highly Cited
2000
Diperoxovanadate (DPV), a potent tyrosine kinase activator and protein tyrosine phosphatase inhibitor, was utilized to explore… 
2000
2000
Reactive oxygen species (ROS) generated by activated leukocytes play an important role in the disruption of endothelial cell (EC… 
Highly Cited
1999
Highly Cited
1999
Inflammatory diseases of the lung are characterized by increases in vascular permeability and enhanced leukocyte infiltration… 
1995
1995
On incubation with catalase diperoxovanadate was found to be degraded, showing a decrease in its absorbance at 356 nm and a loss…